Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Non-Current Deferred Tax Liability (2009 - 2026)

Updated

Bristol Myers Squibb (BMY) recorded Non-Current Deferred Tax Liability of $228 million in Q3 2026, up 1.3% from $225 million a year earlier and up 2.7% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends

At the end of FY2025, Bristol Myers Squibb reported Non-Current Deferred Tax Liability of $222 million, down 39.8% from FY2024.

  • Annual Non-Current Deferred Tax Liability has a five-year compound annual growth rate of -47.2% (FY2020 to FY2025).
  • Across earlier years, Non-Current Deferred Tax Liability came in at $369 million in FY2024 (+9.2%), $338 million in FY2023 (-84.4%), $2.17 billion in FY2022 (-51.9%) and $4.5 billion in FY2021 (-16.8%).
  • The Q3 2026 figure is the highest quarterly Non-Current Deferred Tax Liability since Q2 2025.
  • On a year-over-year basis, Non-Current Deferred Tax Liability rose in two of the last eight quarters, with an average decline of 24.3%.
  • Peak year-over-year performance for Non-Current Deferred Tax Liability in the last five years was growth of 9.2% in Q4 2024, against a decline of 86.2% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $222 million (Q2 2026), $211 million (Q1 2026) and $222 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 228.00 Mn
Jun 30, 2026 222.00 Mn
Mar 31, 2026 211.00 Mn
Dec 31, 2025 222.00 Mn
Sep 30, 2025 225.00 Mn
Jun 30, 2025 247.00 Mn
Mar 31, 2025 276.00 Mn
Dec 31, 2024 369.00 Mn
Sep 30, 2024 430.00 Mn
Jun 30, 2024 461.00 Mn
Mar 31, 2024 442.00 Mn
Dec 31, 2023 338.00 Mn
Sep 30, 2023 399.00 Mn
Jun 30, 2023 751.00 Mn
Mar 31, 2023 1.57 Bn
Dec 31, 2022 2.17 Bn
Sep 30, 2022 2.88 Bn
Jun 30, 2022 3.03 Bn
Mar 31, 2022 3.81 Bn
Dec 31, 2021 4.50 Bn
API Access

Bristol Myers Squibb Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=BMY&period=max&api_key=YOUR_API_KEY